(NYSE: PRGO) Perrigo Co's forecast annual revenue growth rate of 0.86% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 7.79%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.13%.
Perrigo Co's revenue in 2026 is $4,178,400,000.On average, 6 Wall Street analysts forecast PRGO's revenue for 2026 to be $580,591,162,920, with the lowest PRGO revenue forecast at $553,332,712,230, and the highest PRGO revenue forecast at $602,038,167,270. On average, 6 Wall Street analysts forecast PRGO's revenue for 2027 to be $586,679,344,800, with the lowest PRGO revenue forecast at $558,037,216,410, and the highest PRGO revenue forecast at $615,183,105,420.
In 2028, PRGO is forecast to generate $593,320,997,760 in revenue, with the lowest revenue forecast at $564,540,501,600 and the highest revenue forecast at $615,598,208,730.